Emiko Sano
Tokyo, 1738610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Differentiation therapy targeting indoleamine 2,3-dioxygenase 1 in glioblastoma cells in vitro.
Journal: Molecular and clinical oncology
Published: October 21, 2025
Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
Journal: Oncology reports
Published: July 20, 2022
Anti-tumor effects of perampanel in malignant glioma cells.
Journal: Oncology letters
Published: July 04, 2022
Interleukin-6 sensitizes TNF-α and TRAIL/Apo2L dependent cell death through upregulation of death receptors in human cancer cells.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: July 12, 2020
Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells.
Journal: Oncology letters
Published: April 02, 2020
Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Journal: Biochemical and biophysical research communications
Published: December 26, 2019
Antitumor effect of lenalidomide in malignant glioma cell lines.
Journal: Oncology reports
Published: June 24, 2019
Promotion of TRAIL/Apo2L-induced apoptosis by low-dose interferon-β in human malignant melanoma cells.
Journal: Journal of cellular physiology
Published: September 11, 2018
Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy.
Journal: International journal of oncology
Published: March 03, 2018
Efficacy of ribavirin against malignant glioma cell lines: Follow-up study.
Journal: Oncology reports
Published: July 25, 2017
Production and characterization of genetically modified human IL-11 variants.
Journal: Biochimica et biophysica acta. General subjects
Published: July 31, 2016
Last Updated: 09/26/2026